U.S. Bancorp Valuation
Is UB5 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of UB5 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: UB5 (€49.51) is trading below our estimate of fair value (€98.44)
Significantly Below Fair Value: UB5 is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for UB5?
Key metric: As UB5 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is UB5's PE Ratio? | |
|---|---|
| PE Ratio | 15.5x |
| Earnings | US$5.09b |
| Market Cap | US$79.16b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | n/a |
| Enterprise Value/EBITDA | n/a |
| PEG Ratio | 1.3x |
Price to Earnings Ratio vs Peers
How does UB5's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 11.8x | ||
CBK Commerzbank | 8.7x | 8.8% | €18.7b |
PCZ ProCredit Holding | 4.3x | 9.9% | €465.3m |
NAB National Australia Bank | 17.1x | 2.3% | AU$121.1b |
PNC PNC Financial Services Group | 17.1x | 12.9% | US$81.3b |
UB5 U.S. Bancorp | 15.5x | 11.6% | €79.2b |
Price-To-Earnings vs Peers: UB5 is expensive based on its Price-To-Earnings Ratio (15.5x) compared to the peer average (11.8x).
Price to Earnings Ratio vs Industry
How does UB5's PE Ratio compare vs other companies in the European Banks Industry?
| 2 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
| 2 Companies | Estimated Growth | Market Cap | |
|---|---|---|---|
Price-To-Earnings vs Industry: UB5 is expensive based on its Price-To-Earnings Ratio (15.5x) compared to the European Banks industry average (7.3x).
Price to Earnings Ratio vs Fair Ratio
What is UB5's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 15.5x |
| Fair PE Ratio | 13.4x |
Price-To-Earnings vs Fair Ratio: UB5 is expensive based on its Price-To-Earnings Ratio (15.5x) compared to the estimated Fair Price-To-Earnings Ratio (13.4x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €49.51 | €51.18 +3.4% | 8.0% | €62.62 | €46.49 | n/a | 21 |
| Nov ’25 | €44.60 | €48.76 +9.3% | 5.9% | €55.16 | €45.05 | n/a | 21 |
| Oct ’25 | €40.46 | €45.06 +11.4% | 5.9% | €51.19 | €39.97 | n/a | 21 |
| Sep ’25 | €42.43 | €45.46 +7.1% | 6.1% | €49.42 | €39.35 | n/a | 22 |
| Aug ’25 | €41.83 | €45.76 +9.4% | 6.7% | €50.79 | €38.79 | n/a | 22 |
| Jul ’25 | €37.08 | €44.16 +19.1% | 7.3% | €49.48 | €39.21 | n/a | 22 |
| Jun ’25 | €36.72 | €43.86 +19.5% | 7.5% | €50.16 | €39.01 | n/a | 22 |
| May ’25 | €38.35 | €44.29 +15.5% | 7.4% | €50.51 | €39.28 | n/a | 22 |
| Apr ’25 | €40.16 | €45.20 +12.6% | 6.9% | €52.14 | €40.96 | n/a | 22 |
| Mar ’25 | €38.22 | €44.37 +16.1% | 8.3% | €56.12 | €40.48 | n/a | 22 |
| Feb ’25 | €39.08 | €44.37 +13.5% | 8.3% | €56.12 | €40.48 | n/a | 22 |
| Jan ’25 | €39.42 | €39.65 +0.6% | 15.5% | €54.21 | €28.01 | n/a | 24 |
| Dec ’24 | €35.62 | €37.78 +6.1% | 17.5% | €57.88 | €28.48 | n/a | 23 |
| Nov ’24 | €30.22 | €38.44 +27.2% | 17.3% | €56.69 | €29.29 | €44.60 | 23 |
| Oct ’24 | €31.48 | €41.30 +31.2% | 14.0% | €59.02 | €34.08 | €40.46 | 23 |
| Sep ’24 | €34.20 | €40.65 +18.9% | 14.3% | €61.54 | €33.07 | €42.43 | 23 |
| Aug ’24 | €35.24 | €39.42 +11.9% | 16.9% | €63.10 | €31.55 | €41.83 | 23 |
| Jul ’24 | €30.24 | €38.97 +28.9% | 20.0% | €63.85 | €30.10 | €37.08 | 23 |
| Jun ’24 | €28.34 | €40.43 +42.7% | 17.4% | €61.02 | €29.14 | €36.72 | 23 |
| May ’24 | n/a | €41.20 0% | 16.1% | €60.78 | €33.57 | €38.35 | 23 |
| Apr ’24 | n/a | €48.81 0% | 12.2% | €62.73 | €35.98 | €40.16 | 23 |
| Mar ’24 | €44.15 | €52.43 +18.7% | 11.6% | €72.99 | €41.71 | €38.22 | 23 |
| Feb ’24 | €45.32 | €50.24 +10.9% | 12.1% | €68.10 | €40.49 | €39.08 | 22 |
| Jan ’24 | €40.42 | €49.27 +21.9% | 13.2% | €65.98 | €40.53 | €39.42 | 22 |
| Dec ’23 | €43.09 | €49.62 +15.2% | 13.6% | €67.45 | €40.85 | €35.62 | 21 |
| Nov ’23 | €43.60 | €51.90 +19.1% | 12.0% | €64.23 | €43.15 | €30.22 | 22 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Crédit Agricole
€40.3b
Provides retail, corporate, insurance, and investment banking products and services in France and internationally.
XCA
€13.40
7D
2.8%
1Y
14.3%
Eurobank Ergasias Services and Holdings
€7.3b
Provides retail banking, corporate and private banking, asset management, treasury, capital market, and other services primarily in Greece, rest of Europe, and internationally.
EFGD
€1.98
7D
-0.08%
1Y
21.5%
Alior Bank
zł11.4b
Provides banking products and services for individuals, businesses, and enterprises in Poland.
A6O
zł19.54
7D
-9.2%
1Y
13.6%